Publications by authors named "Marie-Helene Lafage Proust"

Menopause exacerbates osteoporosis and increases the risk of atherosclerotic plaque rupture, leading to cardiovascular mortality. Osteoporotic women are increasingly treated with teriparatide (TPTD, 1-34 parathyroid hormone), one of the few treatments that stimulate bone formation. Despite the fact that atherosclerotic plaque calcification is a hallmark of plaque development, the impact of TPTD administration on plaque calcification remain unclear.

View Article and Find Full Text PDF

Bone has several crucial functions. It is essential for locomotion and allows our body to stand erect against gravity. A mismatch between the mechanical stresses applied to it and its mechanical resistance leads to fractures.

View Article and Find Full Text PDF
Article Synopsis
  • * The European Renal Osteodystrophy (EUROD) initiative emphasizes the importance of a multidisciplinary team (MDT) approach, bringing together specialists to tackle complex cases of CKD-associated osteoporosis.
  • * The establishment of kidney-bone MDTs is recommended to enhance diagnostics and personalized treatment plans for improve patient management in CKD-MBD across different levels of healthcare.
View Article and Find Full Text PDF

Aging is associated with detrimental bone loss leading to fragility fractures in both men and women. Notably, a majority of bone loss with aging is cortical, as well as a large number of fractures are non-vertebral and at the non-hip sites. Nacre is a product of mollusks composed of calcium carbonate embedded in organic components.

View Article and Find Full Text PDF
Bone and Chronic Kidney Disease.

Semin Musculoskelet Radiol

August 2023

Chronic kidney disease (CKD) induces mineral and bone disorders (CKD-MBD) that affect calcium and phosphate metabolism. This review links pathophysiology, histologic aspects, and radiologic signs. CKD leads to bone lesions, namely renal osteodystrophy, which may combine low or high bone remodeling, impaired mineralization, and bone loss.

View Article and Find Full Text PDF

The coexistence of osteoporosis and chronic kidney disease (CKD) is an evolving healthcare challenge in the face of increasingly aging populations. Globally, accelerating fracture incidence causes disability, impaired quality of life and increased mortality. Consequently, several novel diagnostic and therapeutic tools have been introduced for treatment and prevention of fragility fractures.

View Article and Find Full Text PDF

Impaired mechanical stimuli during hindlimb unloading (HLU) are believed to exacerbate osteocyte paracrine regulation of osteoclasts. We hypothesized that bone loss and deterioration of the osteocyte lacuno-canalicular network are attenuated in HLU mice housed at thermoneutrality (28 °C) compared with those housed at ambient temperature (22 °C). Following acclimatization, 20-week-old male C57BL/6J mice were submitted to HLU or kept in pair-fed control cages (CONT), for 5 days (5d) or 14d, at 22 °C or 28 °C.

View Article and Find Full Text PDF

To evaluate whole-body vibration (WBV) osteogenic potential in physically inactive postmenopausal women using high-frequency and combined amplitude stimuli. Two-hundred fifty-five physically inactive postmenopausal women (55-75 years) with 10-year major osteoporotic fracture risk (3%-35%) participated in this 18-month study. For the first 12 months, the vibration group experienced progressive 20-min WBV sessions (up to 3 sessions/week) with rest periods (30-60 s) between exercises.

View Article and Find Full Text PDF

Nacre has emerged as a beneficial natural product for bone cells and tissues, but its effect was only studied by gavage in the ovariectomized mouse model. We sought to assess the antiosteoporotic effect of nacre through a nutritional supplementation in the ovariectomized rat model. Sixteen-week-old female Wistar rats were either Sham-operated or bilateral ovariectomized (OVX) and then fed with standard diet (Sham and OVX groups) or standard diet supplemented with either 0.

View Article and Find Full Text PDF
Article Synopsis
  • - Bone metastases are common in breast cancer, leading to abnormal blood vessel growth and bone damage, prompting researchers to test anti-angiogenic drugs (AAD) as a treatment strategy.
  • - This study aimed to investigate how AAD affects the growth of blood vessels in bone during breast cancer metastasis by using advanced imaging techniques on mice treated with different combinations of AAD.
  • - Results showed that early AAD treatment improved bone volume but later reduced the thickness of blood vessels, indicating it initially protects against bone loss but eventually alters bone blood vessel structure.
View Article and Find Full Text PDF

Osteoarthritis (OA) is a whole joint disease characterized by an important remodeling of the osteochondral junction. It includes cartilage mineralization due to chondrocyte hypertrophic differentiation and bone sclerosis. Here, we investigated whether gremlin-1 (Grem-1) and its BMP partners could be involved in the remodeling events of the osteochondral junction in OA.

View Article and Find Full Text PDF
Article Synopsis
  • - X-linked hypophosphatemia (XLH) is a genetic disorder linked to PHEX gene mutations that leads to high levels of FGF23, resulting in low phosphate levels and bone issues, including osteomalacia in adults and rickets in children, often causing chronic pain and reduced quality of life.
  • - Current treatments involve frequent oral intake of phosphate and active vitamin D, which can have negative side effects and poor compliance among patients, while new treatment options like burosumab, an anti-FGF23 antibody, show promise, particularly in adult patients.
  • - Burosumab was found to significantly improve phosphate levels, enhance fracture healing, and reduce pain and disability in adults with XLH, with long-term studies indicating a
View Article and Find Full Text PDF

The worldwide global increase in serum 25-hydroxyvitamin D (25(OH)D) measurements has led some countries to restrict reimbursement for certain clinical situations only. Another approach could consist in providing physicians with screening tools in order to better target blood test prescription. The objective of the SCOPYD study was to identify the best combination of predictors of serum VitD concentration among adults aged 18-70 years.

View Article and Find Full Text PDF

Chronic kidney disease is defined as a decrease in renal function or evidence of kidney injury for >3 months. This represents an oversimplification that may confuse physicians. Thus kidney function is equated to glomerular filtration rate, which represents one of multiple kidney functions.

View Article and Find Full Text PDF

Insights into the effects of osteoarthritis (OA) and physical interventions on the musculoskeletal system are limited. Our goal was to analyze musculoskeletal changes in OA mice and test the efficacy of 8-week exposure to hypergravity, as a replacement of physical activity. 16-week-old male (C57BL/6J) mice allocated to sham control and OA groups not centrifuged (Ctrl 1g and OA 1g, respectively) or centrifuged at 2g acceleration (Ctrl 2g and OA 2g).

View Article and Find Full Text PDF

Controlling the excessive fracture burden in patients with chronic kidney disease (CKD) Stages G4-G5D remains an impressive challenge. The reasons are 2-fold. First, the pathophysiology of bone fragility in patients with CKD G4-G5D is complex and multifaceted, comprising a mixture of age-related (primary male/postmenopausal), drug-induced and CKD-related bone abnormalities.

View Article and Find Full Text PDF

Background And Objectives: Histomorphometric analysis of a transiliac bone biopsy is the gold standard for the diagnosis of renal osteodystrophy (ROD). This procedure is costly, invasive and usually performed with a trephine with an internal diameter of 7.5 mm.

View Article and Find Full Text PDF
Article Synopsis
  • Severe uncontrolled secondary hyperparathyroidism and a history of kidney transplantation increase the risk of fractures in hemodialyzed patients, and those returning to dialysis after transplant failure face greater health challenges than transplant-naive patients.
  • A study comparing 29 transplant failure patients to 58 transplant-naive patients showed that while initial parathyroid hormone and vitamin D levels were similar, transplant failure patients had significantly higher parathyroid hormone levels and rates of uncontrolled secondary hyperparathyroidism after one year of dialysis.
  • The findings indicate that younger patients with transplant failures are particularly at risk for developing severe secondary hyperparathyroidism, highlighting the need for close monitoring and management in this population.
View Article and Find Full Text PDF

Intermittent parathyroid hormone (iPTH) is anti-osteoporotic and affects bone vessels. Transitional capillaries close to the bone surface, which express both endomucin (Edm) and CD31, bear leptin receptor-expressing (LepR) perivascular cells that may differentiate into osteoblasts. Increased numbers of type H endothelial cells (THEC; ie, Edm /CD31 cells assessed by flow cytometry, FACS) are associated with higher bone formation in young mice.

View Article and Find Full Text PDF

Osteogenesis imperfecta (OI) is a genetic disease whose clinical phenotype and severity vary considerably. The increased risk of fractures due to bone fragility persists in adulthood, notably after 40 years of age, albeit at a lower level than during growth. Adults with OI require periodic evaluations of the other manifestations of OI including hearing loss, respiratory impairments, ocular and dental abnormalities, and cardiovascular disease.

View Article and Find Full Text PDF
Article Synopsis
  • Secondary hyperparathyroidism (SHPT) often complicates renal disease, especially in patients undergoing hemodialysis, and this study aimed to track mineral metabolism changes and identify risk factors over 36 months of treatment.
  • Researchers monitored serum levels of parathyroid hormone (PTH), calcium, phosphate, and bone-specific markers, finding that while PTH initially dropped, it eventually increased significantly, linked to the correction of calcium and phosphorus levels.
  • Severe SHPT occurred in 18% of patients, with higher baseline PTH and CTX levels indicating greater risk, highlighting that female sex, along with elevated starting levels, can predict the development of severe SHPT.
View Article and Find Full Text PDF

Chronic kidney disease (CKD) is a risk factor for fractures. The current evaluation of fracture risk is based upon the combination of various clinical factors and quantitative imaging of bone. X-ray-based tools were developed to evaluate bone status and predict fracture risk.

View Article and Find Full Text PDF

Renal osteodystrophy (ROD) is a heterogeneous group of metabolic bone diseases complicating progressive chronic kidney disease (CKD). Bone biomarkers and bone imaging techniques may help to assess bone health and predict fractures in CKD but do have important inherent limitations. By informing on bone turnover and mineralization, a bone biopsy may help to guide prevention and treatment of ROD and its consequences.

View Article and Find Full Text PDF